Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.38 |
| ▸ | VCP | P55072 | 1/20 | 0.35 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL513334 | 0.81 | CA2 (0.39) | CA2PTGS1PTGS2VCP | |
| SCHEMBL1964848 | 0.81 | L3MBTL1 (0.47) | CA2PTGS1PTGS2AGTR2 | |
| SCHEMBL513962 | 0.79 | PTGS1 (0.39) | CA2PTGS1PTGS2 | |
| SCHEMBL2579885 | 0.77 | GRIN1 (0.40) | CA2PTGS1PTGS2 | |
| SCHEMBL515027 | 0.74 | CA2 (0.39) | CA2PTGS1PTGS2 | |
| SCHEMBL513997 | 0.74 | PTGS1 (0.39) | CA2PTGS1PTGS2VCP | |
| SCHEMBL24370477 | 0.74 | PTGS1 (0.42) | CA2PTGS1PTGS2AGTR2 | |
| SCHEMBL1963457 | 0.74 | PTGS1 (0.42) | CA2PTGS1PTGS2AGTR2 | |
| SCHEMBL1967281 | 0.73 | MAPT (0.54) | CA2PTGS1PTGS2 | |
| SCHEMBL1966561 | 0.73 | PTGS1 (0.39) | CA2PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2420493-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | Nissan Chemical Industries, Ltd. (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | CBR3, CBR1, HDHD5 | CA2 200/4885PTGS1 3479/4885PTGS2 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.